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Abstract. 
 
Growth factor–induced signaling by receptor
tyrosine kinases (RTKs) plays a central role in embry-
onic development and in pathogenesis and, hence, is
tightly controlled by several regulatory proteins. Re-
 
cently, Sprouty, an inhibitor of 
 
Drosophila
 
 develop-
ment-associated RTK signaling, has been discovered.
Subsequently, four mammalian Sprouty homologues
(Spry-1–4) have been identiﬁed. Here, we report the
 
functional characterization of two of them, Spry-1 and
-2, in endothelial cells. Overexpressed Spry-1 and -2 in-
hibit ﬁbroblast growth factor– and vascular endothelial
growth factor–induced proliferation and differentiation
by repressing pathways leading to p42/44 mitogen-acti-
 
vating protein (MAP) kinase activation.
 
 
 
In contrast, al-
though epidermal growth factor–induced proliferation
of endothelial cells was also inhibited by Spry-1 and -2,
activation of p42/44 MAP kinase was not affected. Bio-
chemical and immunoﬂuorescence analysis of endoge-
nous and overexpressed Spry-1 and -2 reveal that both
Spry-1 and -2 are anchored to membranes by palmitoy-
lation and associate with caveolin-1 in perinuclear and
vesicular structures. They are phosphorylated on serine
residues and, upon growth factor stimulation, a subset
is recruited to the leading edge of the plasma mem-
brane. The data indicate that mammalian Spry-1 and -2
are membrane-anchored proteins that negatively regu-
late angiogenesis-associated RTK signaling,
 
 
 
possibly in
a RTK-speciﬁc fashion.
Key words: angiogenesis • endothelial cells • ﬁbro-
blast growth factors • signal transduction • vascular en-
dothelial growth factor
 
Introduction
 
Many organs, including lung, kidney, some glands, and in
particular the vascular system, are composed of a network
of tubes. The formation of these three-dimensional struc-
tures involves the coordination of several cellular pro-
cesses, such as the specification of cell fate, changes in cell
shape, migration, and proliferation (Metzger and Kras-
now, 1999). Many of the molecular mechanisms that un-
derlie the regulation of these complex processes have been
elucidated by studying the development of 
 
Drosophila
melanogaster
 
. Normal development requires the spatial
and temporal regulation of receptor tyrosine kinase
(RTK)
 
1
 
 activities and, recently, a novel negative regulator
of RTK signaling, 
 
Drosophila
 
 Sprouty (DSpry), has been
identified (Hacohen et al., 1998). During the formation of
the tracheal system, DSpry inhibits fibroblast growth fac-
tor (FGF) receptor–mediated branching of epithelial cells
(Hacohen et al., 1998; Placzek and Skaer, 1999). DSpry ap-
peared to block mainly branching of cells lateral to the
FGF signaling center, and it was proposed that DSpry acts
extracellularly as a secreted protein (Hacohen et al., 1998).
More recently, however, Casci and co-workers (1999)
have demonstrated that DSpry is an intracellular protein
lacking a signal peptide for secretion. It is localized to the
inner leaflet of the plasma membrane by its cysteine-rich
domain, where it acts as an inhibitor of FGF receptor– and
epidermal growth factor (EGF) receptor–transduced sig-
nals in wing morphogenesis (Casci et al., 1999). Moreover,
it is found to associate with two intracellular 
 
Drosophila
 
RTK signal transduction components, Gap1 and Drk, and
an SH2-SH3 adaptor protein that is homologous to mam-
malian Grb-2, but not with Sos, Dos, Csw, Ras1, Raf, or
Leo (Casci et al., 1999). Also, DSpry has been found to in-
terfere with FGF receptor– and EGF receptor–mediated
signaling during 
 
Drosophila
 
 eye development and oogene-
sis (Casci et al., 1999; Kramer et al., 1999; Reich et al.,
1999). In the developing eye imaginal disc, the embryonic
chordotonal organ precursors, and the midline glia, EGF
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receptor signaling is part of the regulatory circuit to con-
trol the correct number of neurons and glia, and the loss of
DSpry function results in supernumerary neurons and glia
(Kramer et al., 1999). Since DSpry is also able to interfere
with signaling originating from other RTKs in 
 
Drosophila
 
,
such as Torso and sevenless, it is thought to be a general
inhibitor of RTK signal transduction (Casci et al., 1999;
Reich et al., 1999). However, DSpry’s mode of action has
remained elusive. For example, during eye development,
DSpry appears to inhibit p42/44 mitogen-activating pro-
tein (MAP) kinase activation at the level of Ras (Casci et
al., 1999), whereas during wing development, it may inter-
fere downstream of Raf (Reich et al., 1999).
Since RTK signaling pathways appear to be highly con-
served during evolution, it was conceivable that, in analogy
to DSpry, a mammalian Spry may also regulate RTK signal-
ing during mammalian development and pathogenesis. Re-
cently, three human, four murine, and two avian genes have
been identified that encode protein homologues of DSpry
(Hacohen et al., 1998; de Maximy et al., 1999; Minowada et
al., 1999; Tefft et al., 1999; Chambers and Mason, 2000).
Overexpression of mSpry (mouse Sprouty)-2 and -4 re-
sulted in the repression of FGF-mediated limb develop-
ment in chicken (Minowada et al., 1999), whereas ablation
of Spry-2 expression in cultured embryonic mouse lungs
lead to an increase in lung branching morphogenesis, a pro-
cess that is thought to be induced by FGFs (Tefft et al.,
1999).
 
 
 
Moreover, similar to results obtained in 
 
Drosophila
 
development (Hacohen et al., 1998), expression of mSprys
and chicken Sprys is also upregulated by the FGF signaling
pathway (Minowada et al., 1999; Chambers and Mason,
2000), suggesting a feedback loop involved in the regulation
of growth factor–mediated signal transduction. However, as
in 
 
Drosophila
 
, the mammalian Sprys’ physiological role
and, in particular, the mechanisms by which they inhibit
RTK signaling are also not understood in any detail.
Similar to the tracheal system in 
 
Drosophila
 
, during the
development of the cardiovascular system, the formation of
new blood vessels from preexisting ones (angiogenesis) also
involves sprouting of endothelial cells out of an epithelial
layer and branching of tubular structures (Flamme et al.,
1997). In the adult, angiogenesis only takes place during the
female reproductive cycle, wound healing, and in pathologi-
cal situations, including tumor growth, diabetic retinopathy,
arthritis, atherosclerosis, and psoriasis (Folkman, 1995;
Flamme et al., 1997; Risau, 1997). Angiogenesis is tightly
regulated by a balance between inducing and inhibitory sig-
nals (Hanahan and Folkman, 1996; Hanahan, 1997). Pep-
tide growth factors, such as vascular EGF (VEGF), FGF,
and angiopoietins, by binding to their cognate RTKs, posi-
tively regulate angiogenesis by inducing endothelial cell
proliferation, migration, differentiation, and survival (Ha-
nahan, 1997; Gale and Yancopoulos, 1999). In contrast, fac-
tors that negatively regulate angiogenesis by specifically
blocking RTK signaling are less well characterized.
Motivated by the intriguing similarities in cell biological
processes and gene function between 
 
Drosophila
 
 trachea
development and mammalian angiogenesis, we have in-
vestigated the functional role of mammalian Sproutys in
endothelial cells. Our results demonstrate that Spry-1 and
-2 inhibit FGF- and VEGF-induced endothelial cell prolif-
eration and differentiation, at least in part, by repressing
pathways leading to p42/44 MAP kinase activation. Our
data also demonstrate that Spry-1 and -2 are anchored to
 
membranes by palmitoylation, posttranslationally modi-
fied by phosphorylation, and tightly associated with caveo-
lin-1 in perinuclear and vesicular structures and in the
plasma membrane. Moreover, their expression levels and
their subcellular localization are modulated by growth fac-
tor stimulation. The results indicate that mammalian Sprys
are membrane-anchored proteins that modulate RTK-
mediated signal transduction in endothelial cells.
 
Materials and Methods
 
Cloning
 
Fragments of the cysteine-rich domains of mSpry-1–4 were amplified by
PCR using primers derived from EST sequences homologous to human
Sprouty (hSpry) and DSpry. The amplification products were used to
screen an e14.5 mouse embryo cDNA library in 
 
l
 
GT11 (CLONTECH
Laboratories, Inc.) following the manufacturer’s recommendations. For
all mSprys, the nucleotide sequence of both strands of the coding region
was determined.
 
Adenovirus Vectors
 
The cDNAs encoding mSpry-1 and -2 were subcloned and integrated into
recombinant E1/E3 defective adenoviruses using homologous recombina-
tion in 
 
Escherichia coli
 
 as described (Chartier et al., 1996). All genes of in-
terest were under control of the cytomegalovirus immediate early pro-
moter, followed by a rabbit 
 
b
 
-globin intron/polyadenylation signal. Virus
cultures were initiated by transfecting the linearized genomes into 293
cells using polyethylenimine (Baker et al., 1997). After amplification of
the culture, virus was purified by banding twice on CsCl gradients, trans-
ferred into HBS/40% glycerol by passage over a gel filtration column, and
stored at 
 
2
 
80
 
8
 
C as previously described (Michou et al., 1999). Viral quan-
titation was based on protein content using the conversion of 1 mg viral
protein/3.4 
 
3
 
 10
 
12
 
 virus particles.
 
Cell Culture
 
Human umbilical vein endothelial cells (HUVECs) and mouse microvas-
cular endothelial cells (1G11) (Dong et al., 1997) were cultured in DME
medium supplemented with 20% FCS (GIBCO BRL), 2 mM glutamine,
40 
 
m
 
g/ml bovine brain extract, 80 U/ml heparin, and antibiotics. The me-
dium for bovine capillary endothelial cells (BCEs) was supplemented with
10% FCS and FGF2 (2.5 ng/ml). For viral infections, the culture medium
was replaced with starvation medium (5% FCS for HUVECs, 2% FCS for
BCEs, 0% for 1G11) containing 5,000 particles per cell (PPC). After 4 h,
the medium was replaced with fresh growth medium.
 
DNA Synthesis Assay
 
Endothelial cells were plated in triplicate in 24-well dishes (30,000/well)
and infected with adenoviruses (5,000 PPC) in reduced serum medium for
2–3 h. Cells were starved for 24 h in serum-free 1G11, 2% FCS medium
(BCE), or 5% FCS medium (HUVEC), and then stimulated overnight
with recombinant FGF2 (Promega) or VEGF (R&D Systems). After
stimulation, 1 
 
m
 
Ci of [
 
3
 
H]thymidine (Amersham Pharmacia Biotech) was
added per well, and incorporation of thymidine was determined by scintil-
lation counting as described (Shing et al., 1993).
 
Differentiation Assay
 
HUVECs were infected with 5,000 PPC of adenoviruses; after 4 d, they
were resuspended in 5% FCS medium and plated in 24-well plates (40,000
cells/well) in the presence of growth factors on a thin layer of Matrigel
(Becton Dickson) diluted 1:1 with 5% FCS medium.
 
Subcellular Fractionation
 
HUVECs (10
 
6
 
) were infected with AdmSpry-1, or AdeGFP; and, after
48 h, the cells were extracted with 90 mM KAc, 2.5 mM MgCl
 
2
 
, 1 mM
EDTA, 0.2 mM CaCl
 
2
 
, 12 mM glucose, 0.003% digitonin, 0.5 mM NaVO
 
4
 
,
10 mM NaF, 10 mM Pefabloc, 1 mM aprotinin, 1 mM leupeptin. After 7
min on ice, the supernatant (cytoplasmic extract) was collected, and the
remaining cells were reextracted with Na
 
2
 
CO
 
3
 
 (pH 11). After 10 min on
ice, the supernatant (peripheral membrane protein 1) was collected. The
remaining cells were homogenized in PBS and centrifuged at 1,000 
 
g
 
 to 
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sediment nuclei and unbroken cells. Membranes in the postnuclear super-
natant were pelleted at 100,000
 
 
 
g
 
, and the supernatant was collected (pe-
ripheral membrane protein 2). The membrane pellet was extracted twice
with Na
 
2
 
CO
 
3
 
 for 10 min on ice. Proteins in the aqueous phases (peripheral
membrane proteins 3) were pooled with peripheral membrane protein
fractions 1 and 2, precipitated as described (Oliferenko et al., 1999), and
analyzed by SDS-PAGE and immunoblotting together with the proteins
in the membrane pellet (integral membrane proteins).
 
Flotation Assay
 
Actively proliferating HUVECs infected with AdmSpry-1 or AdeGFP
were washed twice with ice-cold PBS, removed from the plates by scrap-
ing in PBS, and centrifuged at 1,000 
 
g
 
 at 4
 
8
 
C. Cells were lysed in 200 
 
m
 
l TN
(25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM DTT, protease inhibitors
as above, 10% sucrose, and 1% Triton X-100) on ice and incubated for 30
min on ice. Samples were mixed with 400 
 
m
 
l ice-cold Optiprep™, trans-
ferred into SW60 centrifuge tubes, and overlaid with each 600 
 
m
 
l of 35, 30,
25, 20, and 0% Optiprep™ in TN. The gradients were centrifuged at
35,000 rpm in a SW60 rotor for 12 h at 4
 
8
 
C. Fractions were collected from
top to bottom of the centrifuge tubes, and proteins were precipitated and
analyzed by immunoblotting.
 
Immunoblotting
 
Total cell lysates, protein fractions, or immunoprecipitates was analyzed
by SDS-PAGE and immunoblotting as described (Yu and Sato, 1999).
Rabbit sera against mSpry-1 and -2 were generated with peptides corre-
sponding to the NH
 
2
 
-terminal residues AVEGRQRLDYDRDTQ of
mSpry-1 and HERLHGLPEHRQPPRLQPSQVHSSRAP of mSpry-2
conjugated to keyhole limpet hemocyanin. Antibodies from rabbit sera
were affinity purified on antigenic peptides coupled to Sepharose. The
specificity of the antibodies against mSpry-1 and  -2 was further confirmed
by peptide competition experiments, as well as by excluding cross-reactiv-
ity with mSpry-4. The following antibodies against other proteins were
used: p42/44 MAP kinase and total p42/44 MAP kinase (Sigma-Aldrich),
activated MAP kinase kinase (MEK) and total MEK (New England
Biolabs, Inc.), 
 
b
 
-catenin and caveolin-1 (Signal Transduction Laborato-
ries), lactate dehydrogenase (LDH) (Chemicon International Ltd.), an-
nexin II (Santa Cruz Biotechnology, Inc.), transferrin receptor (a gift from
L. Huber, Research Institute of Molecular Pathology, Vienna, Austria).
 
Immunofluorescence
 
HUVECs were plated on gelatine-coated glass coverslips and grown to
70% confluency. For the stimulation experiments, the cells were starved
for 24 h and then stimulated with 10 ng/ml FGF2 for various times. The
cells were rinsed twice with PBS, fixed with 3% paraformaldehyde in PBS
for 20 min at room temperature, permeabilized with 0.3% Triton X-100
for 3 min on ice, and washed with PBS. After blocking first with 3% BSA/
PBS and then with 1% goat serum/0.1% BSA/PBS, the cells were incu-
bated with the primary antibody for 30 min at room temperature and were
washed with 0.1% BSA/PBS, followed by 30 min incubation with a sec-
ondary antibody conjugated to a fluorochrome. After washing with 0.05%
Tween-20 in 0.1% BSA/PBS, the coverslips were mounted onto slides in
mounting medium. Mouse monoclonal antibodies against caveolin-1, syn-
taxin-4, ergic-53, giantin, protein disulfide isomerase, transferrin receptor,
and VE–cadherin were from Signal Transduction Laboratories; secondary
antibodies anti–rabbit or anti–mouse IgG (Cy2 or Cy3 conjugated) were
from Jackson ImmunoResearch Laboratories.
 
Immunoprecipitations
 
HUVECs infected with AdmSpry-1, AdmSpry-2, or AdeGFP were lysed
in different extraction buffers (150 mM NaCl, 10 mM Tris, 10 mM NaF, 2
mM Na
 
3
 
VO
 
4
 
, 10 mM Pefabloc, 1 mM aprotinin, 1 mM leupeptin, 1 mM
DTT, 1% Triton X-100 or 1% digitonin). After 30 min incubation (at room
temperature for the samples in 1% digitonin and on ice for the samples in
Triton X-100, lysates were cleared by centrifugation (14,000 
 
g
 
 for 30 min),
and equal amounts of lysates were immunoprecipitated with anti-Spry an-
tibodies and protein G agarose at 4
 
8
 
C. The immunoprecipitates were
washed three times at room temperature with the corresponding lysis buff-
ers; immunoprecipitated proteins were resolved by 12% SDS-PAGE.
 
Radiolabeling
 
HUVECs infected with AdmSpry-1 or -2 were metabolically labeled with
[
 
35
 
S]methionine/[
 
35
 
S]cysteine (Amersham Life Science) in methionine and
cysteine serum-free medium for the time indicated, or with [
 
3
 
H]palmitate
(30–60 Ci/mmol; DuPont) in DME containing 10% FCS for 2 h. For or-
thophosphate labeling, serum-starved HUVECs overexpressing mSpry-1
or mSpry-2 were labeled for 4 h in phosphate-free medium containing 5%
FCS and 1 mCi/ml [
 
32
 
P]orthophosphate (Amersham Life Science) and
then stimulated with FGF2 (10 ng/ml). Cells were then lysed, and mSpry-1
and  -2 were immunoprecipitated with affinity-purified antibodies against
mSpry-1 and  -2, resolved by SDS-PAGE, and visualized by autoradiogra-
phy and fluorography, respectively. For phosphoamino acid analysis, the
proteins were transferred to polyvinyldifluoride membranes and hydro-
lyzed in 6 M HCl for 60 min at 110
 
8
 
C. The hydrolytic products were sepa-
rated in the presence of phosphoserine, phosphothreonine, and phospho-
tyrosine markers in two dimensions on TLC plates (pH
 
 
 
1.9 and 3.5).
 
Results
 
Cloning of mSpry cDNAs
 
ESTs that partially encoded mouse homologues of Sprouty
were identified by their homology to hSpry sequences (Ha-
cohen et al., 1998). DNA fragments were amplified by PCR
and used to screen a cDNA library generated from gesta-
tion day 14.5 mouse embryos. Four different cDNAs were
recovered that were highly homologous to DSpry and
hSpry and that encoded mSpry-1–4 with calculated molecu-
lar masses of 34.4, 34.6, 31.6, and 32.6 kD. All four mSpry
proteins contain in their COOH-terminal region a cysteine-
rich region with at least 23 cysteines; in the alignment of
mSpry, hSpry, and DSpry, this region shows the highest ho-
mology (Fig. 1). However, this highly conserved Sprouty
domain does not exhibit a significant homology to known
functional domains of other proteins. NH
 
2
 
-terminal of the
Sprouty domain, all Spry sequences analyzed contain a
highly conserved serine-rich region (Fig. 1). No significant
homologies between DSpry and mammalian Sprys are ap-
parent at the extreme NH
 
2 
 
and COOH termini. None of
the mammalian Sprys contains predicted signal peptides
for secretion or putative transmembrane domains.
 
mSpry-1 and  -2 Inhibit Endothelial Cell Proliferation 
and Differentiation
 
Motivated by the similarity between the cellular processes
involved in 
 
Drosophila
 
 trachea development and angio-
genesis (see Introduction), we investigated the functional
role of Sprys in endothelial cells. Northern hybridization
Figure 1. Amino acid alignment of the four mSpry proteins
(mSpry-1–4) with hSpry-2 and DSpry. Dashes indicate spaces in-
troduced to maximize alignment. Shaded residues indicate resi-
dues that are identical in at least four of the aligned sequences. A
putative Sprouty domain and a putative serine-rich domain are
underlined by a dotted line and a gray bar, respectively. 
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and reverse transcription–PCR analysis revealed that
Spry-1, -2, and -4 were expressed in primary HUVECs and
in mouse microvascular endothelial cells (1G11) (data not
shown). To assess whether the expression of Sprys in en-
dothelial cells could directly affect angiogenesis, we exam-
ined the influence of Spry expression on endothelial cell
proliferation and differentiation, two processes that are
central to angiogenesis. For these experiments, we used
cultured primary endothelial cells that have not been im-
mortilized, such as HUVECs and BCEs. To obtain high
levels of Spry expression in endothelial cells, we generated
recombinant replication-defective adenoviruses encoding
for mSpry-1 and  -2 (AdmSpry-1 and -2, respectively). Af-
ter infection with adenovirus, HUVECs were stimulated
 
with FGF2, VEGF, or EGF for various time periods. Sub-
sequently, incorporation of [
 
3
 
H]thymidine was used to de-
termine the rate of DNA synthesis (Fig. 2 A), and cell
numbers were determined to calculate proliferation rates
(data not shown). DNA synthesis and proliferation rates
induced by FGF2, VEGF, and EGF were dramatically
reduced in HUVECs overexpressing mSpry-1 or -2,
compared with cells that have been infected with a control
virus expressing enhanced green fluorescent protein (Ade-
GFP; Fig. 2 A). Similar results were obtained with BCEs
(data not shown).
Endothelial cells differentiate into net-like structures
when plated on Matrigel in the presence of growth factors,
such as FGF1, FGF2, or VEGF
 
 
 
(Baatout, 1997; Riccioni et
al., 1998). This differentiation process can be observed
within a few hours after stimulation and does not require
endothelial cell proliferation. To determine whether over-
expression of mSpry might affect endothelial cell differen-
tiation, HUVECs were infected with AdmSpry-1, Adm-
Spry-2, or AdeGFP and subsequently plated on Matrigel
in the presence of FGF2. Under these conditions, nonin-
fected HUVECs or HUVECs infected with AdeGFP
formed stable net-like structures (Fig. 2 B). In contrast,
cells infected with AdmSpry-1 and -2 were significantly
impaired in their ability to elongate and to form net-like
structures (Fig. 2 B). VEGF-stimulated endothelial cell
Figure 2. mSpry-1 and -2 inhibit endothelial cell proliferation
and differentiation. (A) Endothelial cell proliferation. HUVECs
were infected with 5,000 PPC of AdmSpry-1, AdmSpry-2, or
AdeGFP as indicated. 4 h after infection, the cells were starved
and then stimulated with 10 ng/ml FGF2, 10 ng/ml VEGF, or 20
ng/ml EGF. The rate of DNA synthesis was determined by the
incorporation of [3H]thymidine 48 h after infection. Error bars
indicate the standard deviation on the average of three experi-
ments. (B) Endothelial cell differentiation. HUVECs were in-
fected with recombinant adenovirus as described in A and then
plated on Matrigel. Representative microphotographs were
taken 24 h after plating.
Figure 3. Inhibition of p42/44 MAP kinase activation. HUVECs
infected with AdmSpry-1, AdmSpry-2, or AdeGFP were serum
starved 24 h before stimulation with 50 ng/ml VEGF for various
time periods as indicated (A) or with 50 ng/ml VEGF, 50 ng/ml
FGF2, or 20 ng/ml EGF for 10 or 20 min (B). Cells were lysed,
and levels of activated p42/44 MAP kinase, total p42/44 MAP ki-
nase, activated MEK, and total MEK were determined by immu-
noblotting with specific antibodies as indicated. Expression levels
of mSpry-1 and  -2 were determined by stripping and reprobing
the blots with antibodies specific for mSpry-1 or -2 (A). 
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differentiation was inhibited in a similar manner (data not
shown). Together, the data demonstrate that overexpres-
sion of mSpry-1 or -2 inhibits growth factor–induced en-
dothelial cell proliferation and differentiation. In these ex-
perimental settings, mSpry-2 proved to be a less potent
inhibitor than mSpry-1.
 
mSpry-1 and  -2 Inhibit MAP Kinase Activation
 
Previously, it has been reported that DSpry inhibits ty-
rosine kinase receptor signal transduction by inhibiting
pathways that lead to the activation of p42/44 MAP kinase
(Reich et al., 1999). The mitogenic function of the angio-
genic factors FGF and VEGF also requires the activation
of p42/44 MAP kinase (Marshall, 1995; Yu and Sato,
1999). Thus, we investigated whether overexpression of
mSpry is able to affect p42/44 MAP kinase activity. HU-
VECs were infected with AdmSpry-1, AdmSpry-2, or
AdeGFP, and, after serum starvation, the cells were stimu-
lated with VEGF (50 ng/ml) for different times. Activation
of MAP kinase was determined by immunoblotting with
an antibody that specifically recognized the phosphory-
lated (activated) form of p42/44 MAP kinase (Fig. 3 A).
Adenoviral expression of either mSpry-1 or -2 but not of
eGFP resulted in a significant reduction in the levels of ac-
tivated p42/44 MAP kinase, whereas the overall levels of
p42/44 MAP kinase were unaffected, as determined by
probing the immunoblot with an antibody that recognizes
all forms of p42/44 MAP kinase (Fig. 3 A). Adenoviral ex-
pression of mSpry-1 and  -2 was confirmed by probing the
immunoblot with affinity-purified antibodies generated
against mSpry-1 and  -2 peptides (Fig. 3 A).
An inhibition of p42/44 MAP kinase activation by
mSpry-1 and -2 was also observed when HUVECs were
stimulated with FGF2 (Fig. 3 B). Due to the stronger p42/
44 MAP kinase activation by FGF2 compared with VEGF,
Spry-mediated inhibition of FGF2-induced p42/44 MAP
kinase activation appeared less efficient than repression of
VEGF-induced p42/44 MAP kinase activity (Fig. 3 B).
Surprisingly, although EGF-induced proliferation of HU-
VECs was inhibited by mSpry-1 and -2, EGF-mediated ac-
tivation of p42/44 MAP kinase was not at all affected by
Spry overexpression (Fig. 3 B). Probing of the immuno-
blots with antibodies against the phosphorylated (activated)
form of MEK and against all forms of MEK revealed that
mSpry-1 and -2 also repressed FGF2- and VEGF-induced
Figure 4. mSpry-1 and -2 expression is regulated by FGF2 in en-
dothelial cells. Uninfected 1G11 cells were cultured under expo-
nential growth conditions (exp) or serum starved for 48 h and
then stimulated with 10 ng/ml FGF2 for the times indicated.
Northern blot analysis was performed on total RNA isolated
from each time point, using full-length cDNAs for mSpry-1 and
mSpry–2 as probes. Equal loading of RNAs was confirmed by
staining of the gels with ethidium bromide. The lengths of Spry
mRNAs (Kb) and 18S ribosomal RNA are indicated.
Figure 5. Growth factor–induced
recruitment to the plasma mem-
brane. The subcellular localiza-
tion of endogenous hSpry-1 was
determined in HUVECs by im-
munofluorescence microscopy us-
ing an affinity-purified antibody
that specifically recognized
mSpry-1 and hSpry-1 (green) and
Hoechst staining of nuclei (blue).
In actively proliferating endothe-
lial cells (exponential growth),
Spry-1 is localized to the perinu-
clear region, vesicular structures,
and lamellipodia in the leading
edge of the plasma membrane. In
serum-starved cells, Spry-1 is not
found in the plasma membrane
(serum-starved), but a subset of it
is recruited to the plasma mem-
brane 30 min after stimulation
with 10 ng/ml FGF2 (serum-
starved  1 FGF2). Preabsorption
of the affinity-purified antibodies
with corresponding antigenic pep-
tide (1 mg/ml) resulted in a com-
plete abrogation of the immu-
nofluorescence signal (peptide
competition). Bars, 10 mm. 
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but not EGF-induced MEK activation (Fig. 3 B). Adeno-
viral overexpression of mSpry-4 also repressed growth fac-
tor–induced MEK and p42/44 MAP kinase activation
(data not shown).
 
Regulation of mSpry Expression by Angiogenic Factors
 
In 
 
Drosophila
 
, DSpry not only interferes with growth fac-
tor–mediated signal transduction, but the expression of
DSpry is also induced by the factors it subsequently inhib-
its. For example, DSpry expression is induced by FGF dur-
ing trachea development (Hacohen et al., 1998) and EGF
during oogenesis and eye development (Casci et al., 1999;
Reich et al., 1999); in other regions, DSpry expression is
induced with active EGF receptor signaling (Kramer et al.,
1999). During chicken and mouse embryogenesis, Spry ex-
pression was found specifically in centers of FGF signaling
or was upregulated in areas where recombinant FGF was
applied to cultured embryos (Minowada et al., 1999;
Chambers and Mason, 2000). To assess whether Sprys are
regulated in a similar way in endothelial cells upon stimu-
lation with angiogenic factors, HUVECs (data not shown)
and 1G11 cells (Fig. 4) were serum starved and then stimu-
lated with FGF2 for different times. Levels of mRNAs for
endogenous Spry-1 and -2 were determined by Northern
blot hybridization (Fig. 4). Although Spry-1 mRNA was
found at high levels in starved cells, it was transiently
downregulated 2 h after treatment with FGF2 and re-
gained high levels of expression 6 h after growth factor
stimulation. Inhibition of protein synthesis by cyclohexim-
ide during growth factor stimulation prevented the tran-
sient degradation of Spry-1 mRNA (data not shown). In
contrast, expression of Spry-2 (Fig. 4) and -4 (data not
shown) was low in starved cells; it was induced 2 h after
treatment with FGF2 and subsequently downregulated at
later time points. The results indicate that the expression
of Sprys is directly modulated by growth factor stimulation
and that the various members of the Spry family may be
affected in different ways.
 
The Subcellular Localization of mSpry Is Modulated by 
Growth Factors
 
To determine the subcellular localization of Spry-1 and -2
in mammalian endothelial cells, we performed immunoflu-
orescence experiments using affinity-purified polyclonal
Figure 6. Colocalization with
caveolin-1. The localization
of endogenous hSpry-1 was
determined in HUVECs by
confocal immunofluorescent
doublestaining with anti-
bodies specific for hSpry-1
(green) and caveolin-1 (red)
as indicated. Colocalization
was determined by overlay-
ing the green and the red
staining. Note the colocaliza-
tion of Spry-1 with caveolin-1
adjacent to the perinuclear
region, in a subset of vesicu-
lar structures, and in the
plasma membrane (visual-
ized by yellow staining in
the two bottom panels). A
higher magnification of ve-
sicular structures and plasma
membrane (box, bottom left)
is shown in the bottom-right
panel. Bars, 10 mm. 
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antibodies that specifically recognized mSpry-1 and -2
hSpry-1 and -2. In actively proliferating HUVECs, endog-
enous (human) hSpry-1 was widely distributed throughout
the cells; it was found predominantly in perinuclear re-
gions, in vesicular structures, and in the plasma membrane
at the leading edge of the cells (Fig. 5, exponential
growth). Preabsorption of the affinity-purified antibodies
with the corresponding Spry-specific antigenic peptide
completely abrogated the immunofluorescence signal, in-
dicating that the antibodies specifically visualized hSpry-1
(Fig. 5, peptide competition). Upon serum-starvation of
HUVECs, hSpry-1 was found to be absent from the
plasma membrane (Fig. 5, serum-starved). In contrast,
upon stimulation with FGF2 (Fig. 5, serum-starved 
 
1
 
FGF2) or VEGF (data not shown), a small subset of
hSpry-1 was recruited within 30 min to the plasma mem-
brane, mainly to the lamellipodia of the leading edge of
the cells. Identical results were obtained for endogenous
mSpry-1 in 1G11 cells (data not shown). Expression levels
of Spry-2 in endothelial cells were too low to be detected
by immunofluorescence; however, a subcellular localiza-
tion similar to endogenous hSpry-1 was observed when ei-
ther mSpry-1 or mSpry-2 were overexpressed in the cells
by transient transfection or adenoviral gene transfer (data
not shown). Thus, not only Spry gene expression but also
the subcellular localization of Spry proteins is directly
modulated by growth factors.
In an attempt to identify the subcellular structures of
Sprys’ localization, we performed immunohistochemical
double-labeling studies using confocal laser scanning mi-
croscopy. Although Spry-1 was found within the subcellu-
lar compartments identified by some of the markers, it
did not significantly colocalize with protein disulfide
isomerase (PDI; a marker for the ER), ergic-53 (a marker
for the ER/Golgi region), giantin (a marker for the Golgi
network), transferrin receptor (a marker for early endo-
somes), and syntaxin (a marker for secretory vesicles)
(data not shown). In contrast, costaining of Spry-1 with ca-
veolin-1, a cholesterol-binding protein in cholesterol- and
sphingolipid-rich surface domains (lipid rafts) and the ma-
jor structural protein of caveolae (Anderson, 1998), re-
vealed significant colocalization predominantly in the
perinuclear region of the Golgi region and in the plasma
membrane (Fig. 6). Spry-1 and caveolin-1 were also found
to colocalize in vesicular structures; however, a major frac-
tion of the two proteins appeared also to be part of distinct
vesicles. Costaining with VE–cadherin, the predominant
cell–cell adhesion molecule involved in the formation of
adherens junctions in endothelial cells, revealed a mu-
tually exclusive localization: whereas VE–cadherin was
found exclusively in the portions of the cell membrane
that were involved in cell–cell adhesion, Spry-1 was found
in the parts of the plasma membrane that were not in the
vicinity of any neighboring cells (Fig. 7). These results are
consistent with the notion that caveolins are also not local-
ized to the regions of adherens junctions, further support-
ing an association of Sprys with caveolin-containing mem-
brane domains (caveolae).
 
Sprys Are Tightly Associated with Membranes and
with Caveolin-1
 
Next, we performed coimmunoprecipitation experiments
to assess whether Sprys could directly associate with cave-
olin-1. HUVECs infected with AdmSpry-1 or AdeGFP
were lysed in buffers that differed in their strength of
membrane disaggregation: 1% Triton X-100 for solubiliza-
tion of conventional membranes, and 1% digitonin for the
quantitative depletion of cholesterol from cholesterol-rich
membrane domains (rafts). Under these different buffer
conditons, mSpry-1 was immunoprecipitated with antibod-
ies specific for Spry-1, and precipitated mSpry-1 and co-
precipitated caveolin-1, respectively, were analyzed by im-
munoblotting (Fig. 8 A). These experiments revealed that
overexpressed mSpry-1 was tightly associated with caveo-
lin-1, even under conditions known to disrupt lipid rafts
(Fig. 8 A). A similar caveolin-1 association was also ob-
served for overexpressed mSpry-2 (data not shown). Con-
trol immunoprecipitations using unrelated rabbit immuno-
globulins did not precipitate caveolin-1 (Fig. 8 A, right).
Moreover, annexin II, a peripheral membrane protein, did
not coprecipitate with mSpry-1, confirming a specific asso-
ciation between overexpressed mSpry-1 and caveolin-1. In
AdeGFP-infected HUVECs, precipitation of endogenous
hSpry-1 did not recover significant amounts of hSpry-1
and caveolin-1, most likely due to the low levels of endog-
enous hSpry-1 in HUVECs (Fig. 8 A). Notably, immuno-
precipitations of caveolin-1 did not recover detectable
Figure 7. Colocalization with VE–cadherin. Confocal immunofluorescent doublestaining of HUVECs with antibodies specific for
hSpry-1 (green) and VE–cadherin (red) as indicated. Colocalization was determined by overlaying the green and the red staining. Note
the mutual exclusive localization of Spry-1 and VE–cadherin in the plasma membrane. Bars, 10 mm. 
The Journal of Cell Biology, Volume 152, 2001 1094
 
amounts of overexpressed mSpry-1, raising the possibility
that only a subset of caveolin-1 is associated with mSpry-1
(data not shown).
To characterize the membrane association of Sprys, we
performed biochemical fractionation experiments. Ac-
tively proliferating HUVECs infected with either Adm-
Spry-1 or AdeGFP were permeabilized with 0.003%
digitonin to extract the cytoplasm. The remaining mem-
brane-associated proteins were further separated into pe-
ripheral membrane proteins and integral membrane pro-
teins by washing the membranes with sodium carbonate
(Fig. 8 B) or using a Triton X-114 extraction protocol (data
not shown). Under both extraction conditions, overex-
pressed mSpry-1 was not released from the membranes; it
cofractionated exclusively with transferrin receptor and
caveolin-1, both prototype integral membrane proteins
(Fig. 8 B, lanes 5 and 6). In contrast, the peripheral mem-
brane protein 
 
b
 
-catenin was quantitatively released from
the membranes under these conditions (Fig. 8 B, lanes 3
 
and 4). LDH was used as a marker for cytoplasmic pro-
teins (Fig. 8 B, lanes 1 and 2). Under the Ca
 
2
 
1
 
 concentra-
tion used, the peripheral membrane protein annexin II dis-
sociated from membranes and was predominantly found
in the cytoplasmic fraction, whereas only a subset re-
mained in the peripheral membrane fraction (Fig. 8 B,
lanes 1–4). Similar results were obtained for overex-
pressed mSpry-2 in HUVECs (data not shown).
Caveolin-1 is a principal component of cell surface in-
vaginatons called caveolae (Kurzchalia et al., 1992; Roth-
berg et al., 1992). Caveolae represent a subset of lipid rafts,
cholesterol- and sphingolipid-rich membrane microdo-
mains that are functionally implicated in cellular trans-
port processes and in signal transduction–related events
(Simons and Toomre, 2000). The association of mSpry-1
with caveolin-1, thus, raised the question whether mSpry-1
was localized in lipid rafts. To test for this possibility, HU-
VECs were infected with AdmSpry-1 and AdeGFP, re-
spectively, and cells were extracted with Triton X-100,
Figure 8. Sprys are tightly associated with caveolin-1 and membranes. (A) mSpry-1 associates with caveolin-1. HUVECs infected with
AdmSpry-1 or AdeGFP were lysed in digitonin (D) or Triton X-100 (T) buffers, as described in Materials and Methods and indicated
below the lanes. Aliquots of the cell lysates were subjected to immunoprecipitations with antibodies specific for mSpry-1 (top) or unre-
lated rabbit immunoglobulins, as negative control (bottom), in the respective buffers. Precipitated proteins and nonprecipitated pro-
teins (Unbound) were resolved by SDS-PAGE, and caveolin-1, mSpry-1, and annexin II were detected by immunoblotting as indicated.
(B) mSpry-1 is tightly associated with membranes. HUVECs infected with AdmSpry-1 or AdeGFP were subjected to a subcellular frac-
tionation protocol, as described in Materials and Methods. Lanes 1 and 2 (Cyto) show cytoplasmatic extract obtained by permeabilizing
the cells with digitonin (0.003%). Lanes 3 and 4 (Peri) show peripheral membrane proteins washed from partially purified membranes
with sodium carbonate (Na2HCO3). Lanes 5 and 6 (Int) show integral membrane proteins that were not removed from the membrane
fraction by sodium carbonate treatment. Protein levels of mSpry-1, LDH, transferrin receptor (Tf-R), caveolin-1, and annexin II in the
various fractions were determined by immunoblotting as indicated. (C) The majority of mSpry-1 and caveolin-1 are not in detergent-
resistant lipid rafts. HUVECs infected with AdmSpry-1 or AdeGFP were lysed in a Triton X-100 buffer and sedimented on Optiprep
gradients as described in Materials and Methods. mSpry-1, caveolin-1, and annexin II in the gradient fractions were visualized by immu-
noblotting as indicated. The Optiprep concentrations of the fractions are given below the lanes. *Indicates that half of the fractions has
been loaded in these lanes. 
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a procedure that disrupts conventional membranes but
does not affect detergent-resistant lipid rafts (Simons and
Toomre, 2000). Triton X-100 lysates were sedimented on
Optiprep gradients, and the presence of mSpry-1 in the
gradient fractions was analyzed by immunoblotting (Fig. 8
C). These experiments revealed that most of mSpry-1 and
caveolin-1 sedimented as soluble proteins. Only a very
small amount of mSpry-1 and caveolin-1 was found to float
on top of the gradient, indicating that, in cultured endothe-
lial cells, the vast majority of both caveolin-1 and mSpry-1
are not found in detergent-resistant rafts. This result is
somewhat surprising since endothelial cells are known to
contain abundant numbers of caveolae; however, our re-
sults are consistent with previous reports demonstrating
that, in cultured endothelial cells, the majority of caveolin-1
is soluble in Triton X-100 (Venema et al., 1997).
Hence, consistent with the subcellular localization data
(Fig. 6), the immunoprecipitation and the biochemical
fractionation results indicate that, in cultured endothelial
cells, Sprys tightly associate with membranes and with ca-
veolin-1, but the majority of both Sprys and caveolin-1 are
not part of detergent-resistant lipid rafts.
 
mSpry-1 and  -2 Are Phosphorylated and Palmitoylated
 
The membrane association of Spry-1 and -2 and the appar-
ent lack of membrane targeting motifs in their amino acid
sequence, together with the observation that Sprys were
found with varying electrophoretic mobilities (data not
shown), suggested that Sprys are posttranslationally modi-
fied. To examine this, we performed a pulse–chase experi-
ment to investigate the kinetics of mSpry-1 and  -2 bio-
synthesis and processing. HUVECs were infected with
AdmSpry-1 and metabolically labeled with [
 
35
 
S]methio-
nine/cysteine for different times, and mSpry-1 was immu-
noprecipitated from protein lysates and analyzed by SDS-
PAGE. At early time points, mSpry-1 was detected as a
single band with the molecular mass predicted from its
amino acid sequence (34 kD; Fig. 9 A, lane 1). With in-
creasing time of labeling, a second band with lower electro-
phoretic mobility appeared that became predominant at
later times (lanes 2–5). When the pulse experiments were
followed by a chase with normal medium, a complete shift
to the slower migrating form was observed (lane 6). Identi-
cal results were obtained for mSpry-2 (data not shown).
These results raise the possibility that newly synthesized
mSpry-1 and  -2 undergo posttranslational modifications.
The presence of tunicamycin in the culture medium or en-
doglycosidase treatment did not affect the electrophoretic
mobility of mSpry-1 and  -2, excluding protein glycosyla-
tion (data not shown). In contrast, alkaline phosphatase
treatment of uninfected 1G11 cell lysates induced a shift of
endogenous mSpry-1 to a faster migrating form, indicating
that it was modified by phosphorylation (Fig. 9 B). Consis-
tent with this notion, mSpry-1 and  -2 were found to be la-
beled by the incorporation of [
 
32
 
P]orthophosphate in im-
munoprecipitation experiments (Fig. 9 C). However, when
AdmSpry-1- or -2–infected HUVECs were starved and
then stimulated with FGF2, incorporation of [
 
32
 
P]ortho-
phosphate into mSpry-1 and  -2 was not significantly changed
with time (Fig. 9 C). Varying the experimental conditions,
such as timing of the [
 
32
 
P]orthophosphate pulse and growth
factor addition, also did not reveal a strong correlation
between growth factor stimulation and mSpry phosphory-
lation, indicating that phosphorylation of mSprys was not
directly affected by growth factor stimulation (data not
Figure 9. Spry-1 and -2 are post-
translationally modified by phos-
phorylation on serine residues.
(A) Kinetics of posttranslational
modification. HUVECs infected
with AdmSpry-1 were metaboli-
cally labeled with [35S]methio-
nine/cysteine for the times indi-
cated in minutes (pulse). Cell
lysates were either collected im-
mediately, (lanes 1–5) or after the
addition of normal medium for 2 h
(chase; lane 6). mSpry-1 was im-
munoprecipitated, and the state
of its posttranslational modifica-
tion was assessed by the electro-
phoretic mobility of the protein
upon SDS-PAGE and immuno-
blotting. (B) Phosphatase treat-
ment. Total cell lysate from ac-
tively proliferating 1G11 cells was
treated with calf intestine phos-
phatase (lane 2) or with buffer
alone (lane 1), and endogenous
mSpry-1 was detected by immunoblotting. (C) Phosphate labeling. HUVECs infected with AdmSpry-1 or -2 were serum starved, stimu-
lated with 10 ng/ml FGF2, and metabolically labeled with [32P]orthophosphate for the times indicated in minutes. mSpry-1 and  -2 were
immunoprecipitated with affinity-purified antibodies, and the incorporation of radioactivity was analyzed by SDS-PAGE and autora-
diography. Exponentially growing cells were used as control (exp). (D) mSpry-1 and  -2 are phosphorylated on serine residues. Phos-
phoamino acid analysis was performed on the immunoprecipitated mSpry-1 and  -2 proteins described in C. The positions of phos-
phoserine (PS), phosphothreonine (PT), and phosphotyrosine (PY) markers on the thin layer chromatogram are indicated. 
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shown). Phosphoamino acid analysis of [
 
32
 
P]orthophos-
phate-labeled and -immunoprecipitated mSpry-1 and  -2
revealed that both mSpry-1 and  -2 were phosphorylated
exclusively on serine residues (Fig. 9 D).
Next, we analyzed how Sprys associate with membranes.
Extensive protein sequence analysis did not reveal any ap-
parent signal peptide, transmembrane domain, or con-
served motifs known to be modified by prenylation or
myristylation (Veit and Schmidt, 1998). In contrast, Sprys
contain an unusually high number of internal cysteine resi-
dues, amino acids that, via a labile thioester bond, can be
modified by palmitoylation (Veit and Schmidt, 1998). To
investigate the possibility that Sprys were palmitoylated,
HUVECs were infected with AdmSpry-1 and -2, respec-
tively, and metabolically labeled with either [
 
3
 
H]palmitate
or [
 
35
 
S]methionine/cysteine. Subsequently, mSpry-1 and  -2
were immunoprecipitated, and palmitoylation of the pro-
teins was analyzed by SDS-PAGE under nonreducing con-
ditions and fluorography (Fig. 10). Both mSpry-1 and  -2
were specifically labeled by the incorporation of [
 
3
 
H]pal-
mitate. Specific palmitoylation was further confirmed by
soaking the SDS-PAGE gels in hydroxylamine, a treat-
ment that is known to specifically hydrolyze thioester
bonds, such as palmitoylation, but not amide bonds, such
as myristylation (Linder et al., 1995). Such treatment spe-
cifically removed incorporated hydogen-3 from mSpry-1
and  -2 (data not shown). These results demonstrate that
both mSpry-1 and  -2 are palmitoylated, most likely the
molecular basis for their integral membrane localization.
 
Discussion
 
During embryonic development, DSprys, mSprys, and
chicken Sprys have been shown to inhibit growth factor–
mediated signal transduction, at least in part by repressing
pathways that lead to the activation of p42/44 MAP ki-
nases (Hacohen et al., 1998; Casci et al., 1999; Minowada
et al., 1999; Reich et al., 1999); however, their mechanism
of action is not understood. We have addressed some of
the open questions about the molecular mechanisms that
underlie Sprys’ functions. We have cloned four mouse ho-
mologues of hSpry and DSpry and have functionally char-
acterized hSpry-1 and -2 and mSpry-1 and -2 in endothelial
cells. Our data show that mSpry-1 and  -2, when overex-
pressed, inhibit endothelial cell proliferation and differen-
tiation induced by FGF2 and VEGF. At least a fraction of
this inhibitory effect is due to the inhibition of p42/44
MAP kinase activation, certainly upstream of the activa-
tion of MEK, since growth factor–induced MEK activity is
also repressed by Spry-1 and -2. Curiously, although Sprys
efficiently inhibit EGF-induced endothelial cell prolifera-
tion, EGF-mediated p42/44 MAP kinase activation in en-
dothelial cells is not affected by Spry-1 and -2, indicating
that Sprys’ inhibitory functions may not exclusively act by
repressing the MAP kinase pathway. The potential inhibi-
tion of other signaling pathways that are activated by FGF,
VEGF, and EGF receptors remains to be determined.
We also report for the first time the subcellular localiza-
tion of endogenous Spry in mammalian cells. Consistent
with the previously reported localization of Dspry to mem-
branes (Casci et al., 1999), our studies demonstrate a tight
association of Sprys with membranes. First, mSpry-1 and -2
and hSpry-1 and -2 significantly colocalize with caveolin-1
to the perinuclear region, vesicular structures, and the
plasma membranes of endothelial cells. Second, the modifi-
cation by palmitoylation and the lack of glycosylation sug-
gest that Spry-1 and -2 are tightly associated with mem-
branes by a lipid anchor. Third, immunoprecipitation
experiments reveal a tight association between Spry-1,
Spry-2, and caveolin-1, raising the possibility that Sprys are
part of lipid rafts or caveloae (see below; Simons and
Ikonen, 1997; Simons and Toomre, 2000).
Upon growth factor stimulation of starved endothelial
cells, a significant subset of the proteins is translocated to
the plasma membrane, predominantly to the lamellipodia at
the leading edge of the cells, a site where the majority of
growth factor receptors is known to localize. Consistent with
the observations on DSpry reported by Casci and co-work-
ers (1999), we were not able to detect Spry-1 or -2 in the su-
pernatant or in the extracellular matrix of cultured cells,
even when overexpressing the proteins (data not shown).
The specific subcellular localization of mammalian
Sprys and the relocalization induced by growth factors
provides some insights into the mechanisms by which
Sprys inhibit RTK signaling. Several signaling factors, in-
cluding EGF receptor, platelet-derived growth factor re-
ceptor, Src kinases, G
 
a
 
 subunits, phospholipase C 
 
g
 
, pro-
tein kinaes C, Ras, Raf, and MAP kinases, have been
shown to associate with lipid rafts or to cofractionate with
caveolin-1 (Okamoto et al., 1998; Smart et al., 1999).
Hence, lipid rafts and/or caveolae are thought to play an
important role in signal transduction, possibly by assem-
bling signaling complexes or by resetting or recycling re-
ceptors (Liu et al., 1997a,b; Furuchi and Anderson, 1998).
Recently, Simons and Toomre (2000) proposed to distin-
guish four types of lipid rafts: native rafts that are only de-
tectable in living cells, clustered rafts that are induced by
cross-linking, detergent-resistant rafts that are character-
ized by, for example, their resistance to Triton X-100, and
caveolae that are characterized by raft proteins, caveolins
and lipids. Consistent with a previous report (Venema et
al., 1997), our biochemical fractionation experiments with
cultured endothelial cells have revealed that the majority
of caveolin-1 and mSpry-1 is not found in detergent-resis-
tant lipid rafts. Moreover, depletion of cholesterol from
Figure 10. mSpry-1 and  -2 are palmitoylated. HUVECs infected
with AdmSpry-1 (lanes 1 and 3) or -2 (lanes 2 and 4) were labeled
with [3H]palmitate (lanes 1 and 2) or [35S]methionine/cysteine
(lanes 3 and 4) for 2 h. mSpry-1 and  -2 were immunoprecipitated
with affinity-purified antibodies, and radiolabeled mSpry-1 and
-2 were resolved by SDS-PAGE and visualized by fluorography. 
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lipid rafts by treating HUVECs with methyl-
 
b
 
-dextrin
did not affect the inhibitory function of overexpressed
mSpry-1 on VEGF-induced MEK activation (data not
shown), suggesting that functional Spry may not be part of
lipid rafts. On the other hand, the small subset of mSpry-1
that, together with caveolin-1, is found in lipid rafts may
represent functional Spry and may not be affected by
methyl-
 
b
 
-dextrin because it is not exposed on the outer
side of the plasma membrane, for example, within caveo-
lae. Hence, it remains to be elucidated whether their asso-
ciation with caveolin-1 and/or their subcellular localization
brings Sprys into contact with RTK signaling components
to exert their inhibitory function.
DSpry has been shown to directly bind Gap-1 and the
Grb-2 homologue Drk, both adaptor molecules of RTK
signaling pathways (Casci et al., 1999). However, in endo-
thelial cells, under the conditions used to identify caveo–
lin-1 in a tight complex with Spry-1 and -2, these signal-
ing adaptors did not coprecipitate with Sprys (data not
shown). Hence, the molecular mechanisms by which Sprys
negatively modulate RTK signaling remain to be eluci-
dated. Based on the association of Sprys with caveolin-1
and the inability of Sprys to inhibit EGF-induced MAP ki-
nase activation, it is tempting to speculate that Sprys may
not simply interfere with the activation of the MAP kinase
pathway. Rather, they may modulate the assembly of
RTK signaling complexes, promote the resetting of RTK
activity, or play a role in the regulation of RTK recycling.
The latter functions would be compatible with the obser-
vation that in previously published reports (Chambers and
Mason, 2000; de Maximy et al., 1999; Minowada et al.,
1999; Tefft et al., 1999) and, in our experiments, the inhibi-
tory function of vertebrate Sprys is exclusively demon-
strated by overexpression of the proteins. Hence, the func-
tion of endogenous Sprys may differ fundamentally from
the effect of overexpressed Sprys. For example, Sprys,
similar to or together with caveolin-1, may act as scaffold-
ing proteins for the assembly of signaling complexes, and
increasing Spry levels by overexpression may disturb the
stoichiometry of complex assembly and prevent the for-
mation of functional signaling complexes.
Consistent with previous reports on DSpry (Reich et
al., 1999), mSpry, and chicken Spry (Minowada et al.,
1999; Chambers and Mason, 2000) during embryogenesis,
mRNA levels of Spry-1 and -2 are also tightly regulated by
growth factor stimulation in endothelial cells. Notably, ex-
pression of Spry-1 and the expression of Spry-2 appear to
be inversely regulated. Although the expression of Spry-1
is repressed by growth factor stimulation, the expression
of Spry-2 is upregulated. Both Sprys are phosphorylated
on serine residues, however, phosphorylation does not ap-
pear to be modulated by growth factor stimulation, and
the functional role of this modification remains to be eluci-
dated. For example, it is not known whether Spry-1 and -2
phosphorylation is required for their recruitment to the
plasma membrane or for their inhibitory function. Thus,
identification of the Spry phosphorylation sites and/or the
kinase(s) that phosphorylate Sprys may shed some light on
Sprys’ mode of action. Moreover, the observation that
Sprys are palmitoylated membrane proteins and associate
with caveolin-1 sets the stage for future experiments
aimed at unraveling Sprys’ physiological functions.
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Note added in proof. An inhibitory function in angiogenesis of murine
Sprouty-4 has been reported recently by Lee and coworkers (Lee, S.H.,
D.J. Schloss, L. Jarvis, M.A. Krasnow, and J.L. Swain. 2001. J. Biol. Chem.
276:4128–4133).
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